Clinical Trial Update: Quetiapine and the Dopaminergic Epigenetic Control [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on quetiapine focusing on dopaminergic epigenetic control in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED